Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-12

Clinical Trial Update: Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of ophthalmic phentolamine mesylate for open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ophthalmic phentolamine mesylate (phentolamine mesylate)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-07-12